mirror of
https://github.com/msberends/AMR.git
synced 2026-06-29 08:56:20 +02:00
Built site for AMR@3.0.1.9067: 935071a
This commit is contained in:
8
index.md
8
index.md
@@ -181,7 +181,7 @@ wisca(example_isolates,
|
||||
|
||||
| Piperacillin/tazobactam | Piperacillin/tazobactam + Gentamicin | Piperacillin/tazobactam + Tobramycin |
|
||||
|:---|:---|:---|
|
||||
| 70.1% (64.9-75.7%) | 93.6% (92.2-95%) | 89.8% (86.7-92.3%) |
|
||||
| 69.9% (64.7-75.2%) | 93.7% (92.2-95.1%) | 89.8% (86.8-92.3%) |
|
||||
|
||||
WISCA supports stratification by any clinical variable, so you can
|
||||
generate syndrome-specific or ward-specific coverage estimates:
|
||||
@@ -197,9 +197,9 @@ wisca(example_isolates,
|
||||
|
||||
| Syndromic Group | Piperacillin/tazobactam | Piperacillin/tazobactam + Gentamicin | Piperacillin/tazobactam + Tobramycin |
|
||||
|:---|:---|:---|:---|
|
||||
| Clinical | 74.5% (69.3-80.1%) | 93.7% (92-95.1%) | 90.5% (87.1-93.1%) |
|
||||
| ICU | 56.7% (48-65.5%) | 86.7% (83.4-89.8%) | 82.9% (78.2-87.3%) |
|
||||
| Outpatient | 57.8% (46.4-69.7%) | 76.5% (70.1-82.2%) | 67.9% (57.9-77.5%) |
|
||||
| Clinical | 74.6% (69-80.1%) | 93.6% (91.9-95.1%) | 90.5% (86.9-93%) |
|
||||
| ICU | 57% (48.7-65.8%) | 86.7% (83.7-89.7%) | 82.8% (77.9-87.2%) |
|
||||
| Outpatient | 57.5% (46.5-68.7%) | 76.7% (70.6-82.4%) | 67.5% (57.2-76.7%) |
|
||||
|
||||
**For AMR surveillance**, traditional antibiograms remain the right tool
|
||||
for tracking resistance per species over time:
|
||||
|
||||
Reference in New Issue
Block a user